Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2022-02-04 Regulatory Filings
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports the entry into a material definitive agreement (a lease agreement) by the company. The document does not contain financial statements or detailed financial analysis but rather announces a specific corporate event. The length is under 5,000 characters and it is a standalone announcement of a material event, not a full financial report or earnings release. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2022-02-04 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-28 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-28 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-28 English
PRIMARY DOCUMENT
Director's Dealing
2022-01-28 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or agreements. The text describes the entry into a material definitive lease agreement by the company's subsidiary, including details about the lease terms and location. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual report. The document is an announcement of a significant event related to capital or financing activities (leasing property for business use). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive information about the lease agreement, not just a report publication announcement or certification.
2021-12-28 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.